Literature DB >> 21293171

Current and potential roles of ghrelin in clinical practice.

G Angelidis1, V Valotassiou, P Georgoulias.   

Abstract

Ghrelin is a novel GH-releasing peptide, which has been identified as an endogenous ligand for GH-secretagogue receptor. Ghrelin is mainly secreted by the stomach and plays a critical role in a variety of physiological processes including endocrine, metabolic, cardiovascular, immunological, and other actions. Ghrelin stimulates food intake via hypothalamic neurons and causes a positive energy balance and body weight gain by decreasing fat utilization and promoting adiposity. Given the multiple effects of ghrelin, its potential clinical applications have been evaluated in various conditions. Preliminary trials have shown that it may prove valuable in the management of disease-induced cachexia. Ghrelin may improve the wasting syndrome through GH-dependent or GH-independent effects. Moreover, ghrelin may play a role in the management of disorders of gut motility and obesity. Finally, other potential clinical applications of ghrelin include the treatment of patients with diabetes mellitus, infections, rheumatological diseases or GH deficiency and the diagnosis of this hormonal disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21293171     DOI: 10.1007/BF03350350

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  202 in total

1.  Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines.

Authors:  P L Jeffery; R E Murray; A H Yeh; J F McNamara; R P Duncan; G D Francis; A C Herington; L K Chopin
Journal:  Endocr Relat Cancer       Date:  2005-12       Impact factor: 5.678

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.

Authors:  S D Katugampola; Z Pallikaros; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study.

Authors:  L Burdet; B de Muralt; Y Schutz; C Pichard; J W Fitting
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

Review 5.  Growth hormone secretagogues: focus on the growth hormone-releasing peptides.

Authors:  V Locatelli; A Torsello
Journal:  Pharmacol Res       Date:  1997-12       Impact factor: 7.658

6.  Dose-dependent inhibition by ghrelin of insulin secretion in the mouse.

Authors:  Martina Kvist Reimer; Giovanni Pacini; Bo Ahrén
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

7.  Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man.

Authors:  D Ang; H Nicolai; R Vos; K Mimidis; F Akyuz; S Kindt; P Vanden Berghe; D Sifrim; I Depoortere; T Peeters; J Tack
Journal:  Neurogastroenterol Motil       Date:  2008-01-30       Impact factor: 3.598

8.  Calorie and nutrient intakes of elderly and young subjects measured under identical conditions.

Authors:  J J Wurtman; H Lieberman; R Tsay; T Nader; B Chew
Journal:  J Gerontol       Date:  1988-11

9.  Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment.

Authors:  Damien R Ashby; Heather E Ford; Katie J Wynne; Alison M Wren; Kevin G Murphy; Mark Busbridge; Edwina A Brown; David H Taube; Mohammad A Ghatei; Frederick W K Tam; Stephen R Bloom; Peter Choi
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

10.  Circulating ghrelin in patients with gastric or colorectal cancer.

Authors:  Qi Huang; Yue-Zu Fan; Bu-Jun Ge; Qin Zhu; Zhi-Yuan Tu
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

View more
  7 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Pituitary immunoexpression of ghrelin in anorexia nervosa.

Authors:  Fabio Rotondo; Bernd W Scheithauer; Luis V Syro; Angelo Rotondo; Kalman Kovacs
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 3.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

4.  Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.

Authors:  Jeanelle Portelli; Leen Thielemans; Luc Ver Donck; Ellen Loyens; Jessica Coppens; Najat Aourz; Jeroen Aerssens; Katia Vermoesen; Ralph Clinckers; Anneleen Schallier; Yvette Michotte; Dieder Moechars; Graham L Collingridge; Zuner A Bortolotto; Ilse Smolders
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

5.  Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas.

Authors:  Beléen Chanclón; Antonio J Martínez-Fuentes; Francisco Gracia-Navarro
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-18       Impact factor: 5.555

6.  Research on cachexia, sarcopenia and skeletal muscle in cardiology.

Authors:  Andrew J S Coats
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-11-16       Impact factor: 12.910

7.  Growth Hormone: Therapeutic Possibilities-An Overview.

Authors:  Steve Harvey; Carlos G Martinez-Moreno
Journal:  Int J Mol Sci       Date:  2018-07-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.